Aviance Capital Partners’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,750
Closed -$381K 209
2016
Q4
$381K Hold
4,750
0.13% 151
2016
Q3
$379K Hold
4,750
0.13% 147
2016
Q2
$371K Hold
4,750
0.14% 144
2016
Q1
$261K Hold
4,750
0.09% 163
2015
Q4
$293K Hold
4,750
0.1% 157
2015
Q3
$300K Hold
4,750
0.12% 156
2015
Q2
$347K Hold
4,750
0.13% 159
2015
Q1
$311K Hold
4,750
0.11% 181
2014
Q4
$309K Buy
4,750
+140
+3% +$9.02K 0.12% 191
2014
Q3
$277K Buy
4,610
+600
+15% +$39.2K 0.1% 210
2014
Q2
$278K Hold
4,010
0.11% 196
2014
Q1
$262K Buy
4,010
+460
+13% +$29.9K 0.11% 190
2013
Q4
$220K Buy
+3,550
New +$206K 0.09% 193

Other funds holding STJ

Aviance Capital Partners's STJ Position: Q1 2017 in Review

Aviance Capital Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,750 shares — an estimated $381K sold.

Aviance Capital Partners first reported a position in STJ in Q4 2013 and held it in 13 quarters. The position peaked at $381K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Aviance Capital Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Aviance Capital Partners sold 4,750 St Jude Medical shares in Q1 2017, an estimated $381K.
  • Aviance Capital Partners first reported a position in St Jude Medical in Q4 2013 and held it in 13 quarters.
  • Aviance Capital Partners's St Jude Medical position peaked at $381K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Aviance Capital Partners's 13F filing for Q1 2017, filed 12 May 2017.